🔎 Trials Near Me

Hjem › Endometriekreft › Ohio › Cleveland

Kliniske studier for Endometriekreft i Cleveland, OH

20 studier for Endometriekreft søker deltakere på steder i og rundt Cleveland (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.

Offisiell studietekst (engelsk)

Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →

Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer

RekruttererFase 3
  • Case Western Reserve University, Cleveland
  • UHHS-Chagrin Highlands Medical Center, Beachwood · 10 mi unna
  • UH Seidman Cancer Center at Lake Health Mentor Campus, Mentor · 22 mi unna
Alder 18 og eldre · Kvinner · Oppdatert 5. okt. 2026 · NCT07198074

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

RekruttererFase 2
  • Case Western Reserve University, Cleveland
  • UHHS-Chagrin Highlands Medical Center, Beachwood · 10 mi unna
  • UH Seidman Cancer Center at Lake Health Mentor Campus, Mentor · 22 mi unna
Alle aldre · Alle kjønn · Oppdatert 5. okt. 2026 · NCT05564377

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

RekruttererFase 1/2
  • The Cleveland Clinic Taussig Cancer Center, Cleveland
Alder 12 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT04585750

Testing Different Amounts of the Combination of Drugs M1774 and ZEN-3694 for the Treatment of Recurrent Ovarian and Endometrial Cancer

RekruttererFase 1
  • Cleveland Clinic Foundation, Cleveland
Alder 18 og eldre · Kvinner · Oppdatert 2. okt. 2026 · NCT05950464

Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer

RekruttererObservasjonsstudie
  • Cleveland Clinic, Cleveland
Alder 18 og eldre · Kvinner · Oppdatert 29. sep. 2026 · NCT05051722

Study of AVZO-021 in Patients With Advanced Solid Tumors

RekruttererFase 1/2
  • Avenzo Therapeutics Recruiting Site, Cleveland
Alder 18 og eldre · Alle kjønn · Oppdatert 28. sep. 2026 · NCT05867251

Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma

RekruttererFase 2
  • Case Western Reserve University, Cleveland
  • Cleveland Clinic Cancer Center/Fairview Hospital, Cleveland
  • Cleveland Clinic Foundation, Cleveland
  • og 3 flere
Alder 18 og eldre · Kvinner · Oppdatert 28. sep. 2026 · NCT05112601

Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER

RekruttererFase 2
  • Case Western Reserve University, Cleveland
  • UHHS-Chagrin Highlands Medical Center, Beachwood · 10 mi unna
  • UH Seidman Cancer Center, Mentor · 22 mi unna
Alder 18 og eldre · Kvinner · Oppdatert 24. sep. 2026 · NCT05640999

A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

RekruttererFase 1/2
  • UH Cleveland Medical Center, Cleveland
Alder 18 og eldre · Alle kjønn · Oppdatert 17. sep. 2026 · NCT07109726

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

RekruttererObservasjonsstudie
  • Cleveland Clinic, Cleveland
Alder 18 og eldre · Alle kjønn · Oppdatert 14. sep. 2026 · NCT05059444

A Phase 1 Study of LNCB74 in Advanced Solid Tumors

RekruttererFase 1
  • Cleveland Clinic Taussig Cancer Institute, Cleveland
Alder 18 og eldre · Alle kjønn · Oppdatert 21. aug. 2026 · NCT06774963

FOG-001 in Locally Advanced or Metastatic Solid Tumors

RekruttererFase 1/2
  • University Hospitals Cleveland Medical Center, Seidman Cancer Center, Cleveland
  • Cleveland Clinic, Cleveland
Alder 18 og eldre · Alle kjønn · Oppdatert 17. aug. 2026 · NCT05919264

Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors

RekruttererFase 1
  • University Hospital - Cleveland Medical Center, Cleveland
Alder 18 og eldre · Alle kjønn · Oppdatert 5. aug. 2026 · NCT07444814

Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)

RekruttererFase 3
  • Research Site, Cleveland
  • Research Site, Cleveland
Alder 18 og eldre · Kvinner · Oppdatert 29. jul. 2026 · NCT07044336

A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors

RekruttererFase 1
  • University Hospitals Cleveland Medical Center, Cleveland
Alder 18 og eldre · Alle kjønn · Oppdatert 22. jul. 2026 · NCT05208762

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

RekruttererFase 1/2
  • UH Cleveland Medical Center, Cleveland
Alder 18 og eldre · Alle kjønn · Oppdatert 7. jul. 2026 · NCT05768139

First in Human Study of TORL-1-23 in Participants With Advanced Cancer

RekruttererFase 1
  • Cleveland Clinic, Cleveland
Alder 18 og eldre · Alle kjønn · Oppdatert 13. feb. 2026 · NCT05103683

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
  • Cleveland Clinic, Cleveland
Alder 40 og eldre · Alle kjønn · Oppdatert 20. jan. 2026 · NCT05366881

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

RekruttererObservasjonsstudie
  • Massive Bio SYNERGY-AI site, Mayfield Heights · 12 mi unna
Alle aldre · Alle kjønn · Oppdatert 28. okt. 2025 · NCT03452774

Endometriekreft-studier i andre byer

Andre studier i Cleveland

Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.